Can a digestive enzyme combo beat standard painkillers for root canal pain?

NCT ID NCT07759349

First seen Aug 12, 2026 · Last updated Aug 13, 2026 · Updated 1 time

Summary

This trial tests three pain-relief approaches after a single-visit root canal in people with symptomatic irreversible pulpitis, a painful tooth condition. Participants receive either acetaminophen, an NSAID, or a combination of trypsin-chymotrypsin with acetaminophen for three days. Pain levels are measured before treatment and at several points over 72 hours using a standard pain scale. The goal is to see which option provides the best relief after the procedure.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Acetaminophen, NSAIDs (ibuprofen), and a combination of trypsin-chymotrypsin with acetaminophen
What this could lead to
If successful, this could identify the most effective painkiller for post-root-canal discomfort, helping dentists choose better pain management strategies.
What could go wrong
This is a small early-phase trial, so results may not apply to all patients. Pain relief can vary widely, and the study doesn't guarantee long-term benefits or account for all individual differences.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SYMPTOMATIC IRREVERSIBLE PULPITIS (SIP) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Dow University of Health Sciences

    RECRUITING

    Karachi, Sindh, 75600, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.